Table 1.
Baseline characteristics of the patients
| Study ID | Arm | Patients | AGE, Mean ± SD | SEX (Male/Female) | Axial length (mm), Mean ± SD | Spherical equivalent refraction(D), Mean ± SD | Subfoveal choroid thickness (μm), Mean ± SD |
|---|---|---|---|---|---|---|---|
| Xiong 2021 [27] | Treatment | 74 | 10.22 ± 2.38 | 40/ 34 | 25.07 ± 1.15 | − 3.39 ± 2.17 | 288.61 ± 59.59 |
| Control | 74 | 10.33 ± 2.03 | 40 /34 | 25.07 ± 0.87 | − 3.32 ± 1.36 | 286.81 ± 63.67 | |
| Jiang 2022 [12] | Treatment | 119 | 10.46 ± 3.75 | 57/62 | 24.54 ± 0.67 | - 2.49 ± 0.92 | NA |
| Control | 145 | 10.53 ± 3.66 | 73/72 | 24.62 ± 0.86 | - 2.67 ± 1.06 | NA | |
| Tian 2022 [33] | Treatment | 112 | 9.66 ± (1.65) | 55/57 | 24.31 ± 0.92 | -2.17 ± 1.50 | 295 ± 82.98 |
| Control | 112 | 9.47 ± (1.59) | 57/55 | 24.20 ± 0.85 | -2 ± 1.13 | 297.33 ± 81.11 | |
| Chen 2022 [40] | Treatment | 46 | 9.00 ± (1.90) | 27/19 | 24.62 ± 0.97 | - 2.54 ± 1.04 | 259.00 ± 51.46 |
| Control | 40 | 8.98 ± (1.92) | 25/15 | 24.57 ± 0.76 | - 2.29 ± 0.77 | 273.08 ± 54.37 | |
| Dong 2023 [41] | Treatment | 56 | 10.3 ± (2.07) | 26/30 | 24.7 ± 1.04 | - 3.13 ± 1.91 | NA |
| Control | 55 | 9.86 ± (1.41) | 30/26 | 24.6 ± 0.96 | - 2.82 ± 1.86 | NA |